Cover Image

Immune Dysregulation in SARS-CoV-2 patients coinfected with Mycobacterium tuberculosis (Mtb) or HIV in China

Abstract Background SARS-CoV-2 infections usually cause immune dysregulation in the human body. Studies of immunological changes resulting from coinfections with Mycobacterium tuberculosis (Mtb) or HIV are limited. Methods We conducted a retrospective study focusing on patients with COVID-19. A tota...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lei Li (Author), Jianxiang Zhang (Author), Ranran Sun (Author), Hong Liu (Author), Genyang Cheng (Author), Feifei Fan (Author), Chong Wang (Author), Ang Li (Author), Hongxia Liang (Author), Zujiang Yu (Author), Guiqiang Wang (Author), Zhigang Ren (Author)
Format:	Book
Published:	BMC, 2024-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparison of GeneXpert MTB to Mycobacterium tuberculosis culture in children with tuberculosis
by: Betty Agustina, et al.
Published: (2019)

Advances in technology for the laboratory diagnosis of individuals with HIV/AIDS coinfected with Mycobacterium tuberculosis
by: Jin Sun, et al.
Published: (2024)

Immune Dysregulation in Acute SARS-CoV-2 Infection
by: Lauren Grimm, et al.
Published: (2023)

Cutaneous Coinfection of Cytomegalovirus and Mycobacterium chelonae Accelerated by Immunosuppression
by: Yutaka Tsutsumi, et al.
Published: (2021)

Impact of Coinfection With SARS-CoV-2 and Influenza on Disease Severity: A Systematic Review and Meta-Analysis
by: Zhou Guan, et al.
Published: (2021)

SARS-CoV-2 and dengue virus coinfection involving the skin of an Argentinian female
by: Maria V. Rosso, MD, et al.
Published: (2021)

Coinfection of SARS-CoV-2 with other respiratory pathogens in outpatients from Ecuador
by: Diana Morales-Jadán, et al.
Published: (2023)

SARS-CoV-2 and Streptococcus pneumoniae Coinfection in a Previously Healthy Child
by: Kimberly C. Vu, et al.
Published: (2021)

New threatening of SARS-CoV-2 coinfection and strategies to fight the current pandemic
by: Nikky Goel, et al.
Published: (2021)

SARS-Cov-2 and Mycobacterium tuberculosis: A Mini Review
by: Mohsen Ebrahimi, et al.
Published: (2021)

Factors associated with SARS-CoV-2 and community-onset invasive Staphylococcus aureus coinfection, 2020
by: Kelly Jackson, et al.
Published: (2023)

COVID-19 unfolding filariasis: The first case of SARS-CoV-2 and Wuchereria bancrofti coinfection.
by: Mouhand F H Mohamed, et al.
Published: (2020)

Evaluation of Glutathione in Spike Protein of SARS-CoV-2 Induced Immunothrombosis and Cytokine Dysregulation
by: Brandon Norris, et al.
Published: (2024)

Tigecycline resistance may be associated with dysregulated response to stress in Mycobacterium abscessus
by: Hien Fuh Ng, et al.
Published: (2020)

Surviving a Triple Coinfection in an HIV Patient: Tuberculosis Histoplasmosis and SARS-CoV-2: Case Report
by: Julián Martínez, et al.
Published: (2023)

Immunopathogenesis in SARS-CoV-2 and Mycobacterium tuberculosis: The danger of overlapping crises
by: Prakasini Satapathy, et al.
Published: (2022)

Dysregulation of sphingolipid metabolism in pain
by: Jianfeng Wang, et al.
Published: (2024)

Utilization of GeneXpert MTB/RIF Assay for Prevalence Mapping of Rifampicin Resistant Mycobacterium tuberculosis in A Teaching Hospital, Indonesia
by: P. Christopher, et al.
Published: (2020)

In silico discovery and in vitro activity of inhibitors against Mycobacterium tuberculosis 7,8-diaminopelargonic acid synthase (Mtb BioA)
by: Billones JB, et al.
Published: (2017)

Prevalence of bacteria, fungi, and virus coinfections with SARS-CoV-2 Omicron variant among patients with severe COVID-19 in Guangzhou, China, winter 2022
by: Qinghong Fan, et al.
Published: (2024)

Characteristic of 523 COVID-19 in Henan Province and a Death Prediction Model
by: Xiaoxu Ma, et al.
Published: (2020)

Reactive infectious mucocutaneous eruption secondary to SARS‐CoV‐2 and influenza A coinfection with varicella zoster virus reactivation
by: Aref Moshayedi, et al.
Published: (2023)

Re-decontamination of liquid mycobacterial cultures: Additional Mycobacterium tuberculosis yield in the era of Xpert MTB/RIF Ultra in Cape Town, South Africa
by: Dawood da Costa, et al.
Published: (2021)

Designing and Construction of a Cloning Vector Encoding mtb32C and mpt51 Fragments of Mycobacterium Tuberculosis as a DNA Vaccine Candidate
by: Faria Hasanzadeh Haghighi, et al.
Published: (2018)

Emergence of Within-Host SARS-CoV-2 Recombinant Genome After Coinfection by Gamma and Delta Variants: A Case Report
by: Ronaldo da Silva Francisco Junior, et al.
Published: (2022)

Key events in cancer: Dysregulation of SREBPs
by: Yunkuo Li, et al.
Published: (2023)

Lactoferrin Binding to SARS-CoV-2 Spike Glycoprotein Blocks Pseudoviral Entry and Relieves Iron Protein Dysregulation in Several In Vitro Models
by: Antimo Cutone, et al.
Published: (2022)

Regulación inmune durante la coinfección por el virus de la inmunodeficiencia humana y el Mycobacterium tuberculosis Immune regulation during Human Immunodeficiency Virus and Mycobacterium tuberculosis coinfection
by: César Mauricio Rueda, et al.
Published: (2009)

Leishmaniasis and AIDS coinfection
by: Adriana Hozannah, et al.
Published: (2013)

Chikungunya Rickettsial Coinfection
by: Pathum Sookaromdee, et al.
Published: (2022)

Malaria and dengue coinfection
by: Amandeep Kaur, et al.
Published: (2022)

Utilization of GeneXpert MTB/RIF in the Southern Department of Haiti
by: T. Kedia, et al.
Published: (2015)

Use of Xpert MTB/RIF for diagnosis of pediatric tuberculosis in Indonesia
by: Rina Triasih, et al.
Published: (2020)

Necrotising pneumonia caused by Curvularia hawaiiensis (syn. Bipolaris hawaiiensis) and Mycobacterium tuberculosis coinfection in a patient with ascariasis: a case report and review
by: Cristina Aguirre, et al.
Published: (2023)

Coinfection With SARS-CoV-2 and Influenza A(H1N1) in a Patient Seen at an Influenza-like Illness Surveillance Site in Egypt: Case Report
by: Fahim, Manal, et al.
Published: (2021)

Natural Bioactive Molecules as Potential Agents Against SARS-CoV-2
by: Wei Chen, et al.
Published: (2021)

SARS-CoV-2 infection dysregulates the expression of clinically relevant drug metabolizing enzymes in Vero E6 cells and membrane transporters in human lung tissues
by: Chukwunonso K. Nwabufo, et al.
Published: (2023)

A Machine Learning Approach to Determine Risk Factors for Respiratory Bacterial/Fungal Coinfection in Critically Ill Patients with Influenza and SARS-CoV-2 Infection: A Spanish Perspective
by: Alejandro Rodríguez, et al.
Published: (2024)

The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
by: Xi-Ru Zhang, et al.
Published: (2023)

Role of innate immunity in SARS-CoV-2 infection
by: Zihao Wang, et al.
Published: (2023)